You are here

Article info

Article menu
Download PDFPDF
Commentary
The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers

Authors

  • Robert Dood Department of Obstetrics and Gynecology, The University of Utah School of Medicine, Salt Lake City, Utah, USA University of Utah Health Huntsman Cancer Institute, Salt Lake City, Utah, USA PubMed articlesGoogle scholar articles
  • Britton Trabert Department of Obstetrics and Gynecology, The University of Utah School of Medicine, Salt Lake City, Utah, USA University of Utah Health Huntsman Cancer Institute, Salt Lake City, Utah, USA PubMed articlesGoogle scholar articles
  • Theresa L Werner University of Utah Health Huntsman Cancer Institute, Salt Lake City, Utah, USA Department of Medicine, The University of Utah School of Medicine, Salt Lake City, Utah, USA PubMed articlesGoogle scholar articles
  • David Gaffney University of Utah Health Huntsman Cancer Institute, Salt Lake City, Utah, USA Department of Radiation Oncology, The University of Utah School of Medicine, Salt Lake City, Utah, USA PubMed articlesGoogle scholar articles
  • Elke Jarboe University of Utah Health Huntsman Cancer Institute, Salt Lake City, Utah, USA Department of Pathology, The University of Utah School of Medicine, Salt Lake City, Utah, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Robert Dood, Department of Obstetrics and Gynecology, The University of Utah School of Medicine, Salt Lake City, UT 84132, USA; robdood{at}gmail.com

Citation

Dood R, Trabert B, Werner TL, et al
The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers
International Journal of Gynecologic Cancer 2022;32:1087-1088.

Publication history

  • Received May 19, 2022
  • Accepted May 23, 2022
  • First published June 15, 2022.
Online issue publication 
August 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.